{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:51:41Z","timestamp":1793947901799,"version":"4.8.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cmi.2023.10.023","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:03:48Z","timestamp":1698728628000},"page":"1123-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Tuberculosis prevention: current strategies and future directions"],"prefix":"10.1016","volume":"30","author":[{"given":"Anca","family":"Vasiliu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohhei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Mandalakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.10.023_bib1","series-title":"Global tuberculosis report","year":"2022"},{"key":"10.1016\/j.cmi.2023.10.023_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib3","series-title":"WHO operational handbook on tuberculosis. Module 1: prevention - Tuberculosis preventive treatment","year":"2020"},{"key":"10.1016\/j.cmi.2023.10.023_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2023.10.023_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2023.10.023_bib6","doi-asserted-by":"crossref","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","article-title":"Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response","volume":"204","author":"Achkar","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib7","article-title":"The definition of tuberculosis infection based on the spectrum of tuberculosis disease","volume":"17","author":"Migliori","year":"2021","journal-title":"Breathe (Sheff)."},{"key":"10.1016\/j.cmi.2023.10.023_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/aje\/kwx025","article-title":"Transmission of Mycobacterium tuberculosis in households and the community: a systematic review and meta-analysis","volume":"185","author":"Martinez","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2023.10.023_bib9","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00431-021-04000-7","article-title":"Tuberculosis contact investigation results among paediatric contacts in low-incidence settings in Finland","volume":"180","author":"Kontturi","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cmi.2023.10.023_bib10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/cid\/ciz1044","article-title":"Duration of exposure among close contacts of patients with infectious tuberculosis and risk of latent tuberculosis infection","volume":"71","author":"Reichler","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4269\/ajtmh.16-0611","article-title":"Mycobacterium tuberculosis infection in close childhood contacts of adults with pulmonary tuberculosis is increased by secondhand exposure to tobacco","volume":"97","author":"Adetifa","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2023.10.023_bib12","first-page":"300","article-title":"Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development","volume":"56","author":"Chae","year":"2018","journal-title":"J\u00a0Microbiol"},{"key":"10.1016\/j.cmi.2023.10.023_bib13","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/j.cell.2022.10.019","article-title":"An ancestral mycobacterial effector promotes dissemination of infection","volume":"185","author":"Saelens","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2023.10.023_bib14","series-title":"Distribution and origins of Mycobacterium tuberculosis L4 in southeast asia","author":"Ashton","year":"2022"},{"key":"10.1016\/j.cmi.2023.10.023_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01154-2019","article-title":"Accuracy of whole-genome sequencing to determine recent tuberculosis transmission: an 11-year population-based study in Hamburg, Germany","volume":"54","author":"Diel","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12889-022-12527-z","article-title":"The source and fate of Mycobacterium tuberculosis complex in wastewater and possible routes of transmission","volume":"22","author":"Mtetwa","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2023.10.023_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.cmi.2019.03.022","article-title":"Role and value of whole genome sequencing in studying tuberculosis transmission","volume":"25","author":"Nikolayevskyy","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.10.023_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciaa720","article-title":"Evidence for the use of triage, respiratory isolation, and effective treatment to reduce the transmission of Mycobacterium tuberculosis in healthcare settings: a systematic review","volume":"72","author":"Karat","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib19","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1542\/peds.2006-2817","article-title":"Predictors of Mycobacterium tuberculosis infection in international adoptees","volume":"120","author":"Mandalakas","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2023.10.023_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77504-1","article-title":"Increased incarceration rates drive growing tuberculosis burden in prisons and jeopardize overall tuberculosis control in Paraguay","volume":"10","author":"Sequera","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2023.10.023_bib21","first-page":"406","article-title":"Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa","volume":"14","author":"Wood","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib24","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2023.10.023_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.10.023_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M.\u00a0tuberculosis Infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib27","first-page":"56","article-title":"Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Research Centre (ICMR), Chennai","volume":"110","year":"1999","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.cmi.2023.10.023_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/ijmr.ijmr_1540_22","article-title":"Revisiting the chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease","volume":"157","author":"Velayutham","year":"2023","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.cmi.2023.10.023_bib29","series-title":"Essential tuberculosis","first-page":"395","article-title":"The TB vaccine development pipeline: present and future\u00a0priorities and challenges for research and innovation","author":"Kaufmann","year":"2021"},{"key":"10.1016\/j.cmi.2023.10.023_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.750124","article-title":"Vaccine development against tuberculosis over the last 140 years: failure as part of success","volume":"12","author":"Kaufmann","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2023.10.023_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A\u00a0functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2023.10.023_bib33","series-title":"Correlates of vaccine-induced protection: methods and implications","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.cmi.2023.10.023_bib34","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1016\/j.cell.2022.10.025","article-title":"Immune cell interactions in tuberculosis","volume":"185","author":"Flynn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2023.10.023_bib35","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib36","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1016\/j.vaccine.2020.09.055","article-title":"DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: a randomized controlled, double-blind phase 2b trial","volume":"38","author":"Munseri","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.10.023_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00045509","article-title":"Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection","volume":"35","author":"Leidl","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib40","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-\u03b3 release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1164\/rccm.201905-0969OC","article-title":"Quantitative IFN-\u03b3 release assay and tuberculin skin test results to predict incident tuberculosis. A prospective cohort study","volume":"201","author":"Gupta","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib43","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1473-3099(20)30276-0","article-title":"Interferon-\u03b3 release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis","volume":"20","author":"Zhou","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22560","article-title":"Two\u00a0interferon gamma release assays for predicting active tuberculosis: the\u00a0UK PREDICT TB prognostic test study","volume":"22","author":"Abubakar","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.cmi.2023.10.023_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101815","article-title":"Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis","volume":"56","author":"Hamada","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2023.10.023_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169539","article-title":"Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting","volume":"12","author":"Sharma","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.10.023_bib47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1473-3099(21)00261-9","article-title":"The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in\u00a0vitro interferon-\u03b3 release assays: a systematic review and meta-analysis","volume":"22","author":"Krutikov","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib48","series-title":"Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection","year":"2022"},{"key":"10.1016\/j.cmi.2023.10.023_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13568-020-01068-6","article-title":"The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients","volume":"10","author":"Badaro","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.cmi.2023.10.023_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.17816\/PED5346-50","article-title":"Comparative evaluation of innovative diagnostic tests for latent and active T\u0412 infection in children","volume":"5","author":"Lozovskaya","year":"2014","journal-title":"Pediatrician (St Petersburg)"},{"key":"10.1016\/j.cmi.2023.10.023_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017813","article-title":"Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states","volume":"6","author":"Sester","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.10.023_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(19)30282-6","article-title":"Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis","volume":"8","author":"Gupta","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib53","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A\u00a0blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.10.023_bib54","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200604-465OC","article-title":"Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot","volume":"174","author":"Jafari","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1183\/09031936.00096707","article-title":"Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot","volume":"31","author":"Jafari","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02189-2017","article-title":"Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods","volume":"51","author":"Jafari","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/cid\/ciz252","article-title":"Blood transcriptomic stratification of short-term risk in contacts of tuberculosis","volume":"70","author":"Roe","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1473-3099(20)30914-2","article-title":"Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial","volume":"21","author":"Scriba","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib60","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/civ323","article-title":"Flu-like and Other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study","volume":"61","author":"Sterling","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2352-4642(21)00052-3","article-title":"Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study","volume":"5","author":"Malik","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cmi.2023.10.023_bib62","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib64","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib65","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib66","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.5588\/ijtld.18.0168","article-title":"Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review","volume":"22","author":"Hamada","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib67","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0306","article-title":"How could preventive therapy affect the prevalence of drug resistance? Causes and consequences","volume":"370","author":"Kunkel","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.cmi.2023.10.023_bib68","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00388-2022","article-title":"Rifapentine access in Europe: growing concerns over key tuberculosis treatment component","volume":"59","author":"Guglielmetti","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib69","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1813060","article-title":"Isoniazid preventive therapy in HIV-infected pregnant and postpartum women","volume":"381","author":"Gupta","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib70","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01967-2019","article-title":"The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis","volume":"55","author":"Hamada","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.10.023_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033945","article-title":"Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial","volume":"10","author":"Fox","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2023.10.023_bib72","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s13063-018-3070-0","article-title":"Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)","volume":"19","author":"Seddon","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2023.10.023_bib73","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/pathogens11101189","article-title":"Preventive therapy for contacts of drug-resistant tuberculosis","volume":"11","author":"Kherabi","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.cmi.2023.10.023_bib74","series-title":"The end TB strategy","year":"2015"},{"key":"10.1016\/j.cmi.2023.10.023_bib75","series-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","year":"2014"},{"key":"10.1016\/j.cmi.2023.10.023_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2017-210202","article-title":"High prevalence of TB disease in contacts of adults with extrapulmonary TB","volume":"73","author":"Wingfield","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2023.10.023_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6907a1","article-title":"Essential components of a public health tuberculosis prevention, control, and elimination program: recommendations of the advisory council for the elimination of tuberculosis and the National Tuberculosis Controllers Association","volume":"69","author":"Cole","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cmi.2023.10.023_bib78","series-title":"National Institute for health and care excellent guidance and guidelines","year":"2016"},{"key":"10.1016\/j.cmi.2023.10.023_bib79","series-title":"Programmatic management of latent tuberculosis infection in the European Union","year":"2018"},{"key":"10.1016\/j.cmi.2023.10.023_bib80","series-title":"TB action plan for England 2021 to 2026","year":"2021"},{"key":"10.1016\/j.cmi.2023.10.023_bib81","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41591-020-1076-0","article-title":"Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib82","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/ajrccm.161.3.9902005","article-title":"Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis","volume":"161","author":"Schwartzman","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.10.023_bib83","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2105\/AJPH.2010.199505","article-title":"The social determinants of tuberculosis: from evidence to action","volume":"101","author":"Hargreaves","year":"2011","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cmi.2023.10.023_bib84","article-title":"Undernutrition is feeding the tuberculosis pandemic: a perspective","volume":"27","author":"Carwile","year":"2022","journal-title":"J\u00a0Clin Tuberc Mycobact Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib85","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4269\/ajtmh.2009.80.1004","article-title":"Tuberculosis infection in Zambia: the association with relative wealth","volume":"80","author":"Boccia","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2023.10.023_bib86","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(23)01231-X","article-title":"Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial","volume":"402","author":"Bhargava","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.10.023_bib87","first-page":"2552","article-title":"Does direct benefit transfer improve outcomes among people with tuberculosis? \u2013 a mixed-methods study on the need for a review of the cash transfer policy in India","volume":"11","author":"Dave","year":"2022","journal-title":"Int J Health Policy Manag"},{"key":"10.1016\/j.cmi.2023.10.023_bib88","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","article-title":"Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial","volume":"5","author":"Badje","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2023.10.023_bib89","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(21)00387-X","article-title":"Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis","volume":"22","author":"Dhana","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.10.023_bib90","first-page":"CD013693","article-title":"Screening tests for active pulmonary tuberculosis in children","volume":"6","author":"Vonasek","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2023.10.023_bib91","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2011-200933","article-title":"Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting","volume":"68","author":"Mandalakas","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2023.10.023_bib92","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/INF.0000000000003265","article-title":"Symptom-based screening versus chest radiography for TB child contacts: a systematic review and meta-analysis","volume":"40","author":"Vasiliu","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2023.10.023_bib93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5588\/ijtld.17.0492","article-title":"Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening","volume":"22","author":"Melendez","year":"2018","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23005335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23005335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T03:45:26Z","timestamp":1756698326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23005335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1198743X23005335"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.10.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis prevention: current strategies and future directions","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}